VIRAX BIOLABS GROUP LTD (VRAX)
KYG9495L1251 - Common Stock
| 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 120.00K | 100.00K | |||
| Minority Interest Expense | 40.00K | 20.00K | 30.00K | |||
| Cost Of Goods | 0.00 | 130.00K | 50.00K | |||
| Gross Profit | 0.00 | -10.00K | 50.00K | |||
| Operating Expenses | 1.73M | 640.00K | 700.00K | |||
| Research and Development | 430.00K | 120.00K | 90.00K | |||
| Selling, General, and Administrative Expenses | 1.30M | 510.00K | 610.00K | |||
| Operating Income | -1.73M | -640.00K | -650.00K | |||
| Interest Income/Expense | -20.00K | -30.00K | -90.00K | |||
| Other Income/Expense | 0.00 | 0.00 | 0.00 | |||
| Income Before Taxes | -1.75M | -670.00K | -740.00K | |||
| Net Income | -1.71M | -650.00K | -710.00K | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -0.15 | -0.06 | -0.06 | |||
| Statistics | ||||||
| Gross Profit Margin | N/A | -8.33% | 50.00% | |||
| Profit Margin | N/A | -541.67% | -710.00% | |||
| Operating Profit Margin | N/A | -533.33% | -650.00% | |||
All data in USD